HBsAg Test Strip (Test in Whole Blood) |
|||
| HBsAg-213 | Innovation Biotech | 3.0mm (single pouch) 100pouches/box | EUR 0.1 |
Igg Antibody Laboratories manufactures the ccp antibody icg blood test reagents distributed by Genprice. The Ccp Antibody Icg Blood Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Ccp products are available in stock. Specificity: Ccp Category: Antibody Group: Icg Blood
ICG amine |
||
| AAT Bioquest | 5 mg | EUR 421 |
|
Description: Indocyanine green (ICG) is a cyanine dye used in medical diagnostics. |
||
ICG amine |
||
| AAT Bioquest | 5 mg | EUR 412 |
|
Description: Indocyanine green (ICG) is a cyanine dye used in medical diagnostics. |
||
ICG acid |
||
| AAT Bioquest | 5 mg | EUR 227 |
|
Description: Indocyanine green (ICG) is a cyanine dye used in medical diagnostics. |
||
ICG acid |
||
| AAT Bioquest | 5 mg | EUR 222 |
|
Description: Indocyanine green (ICG) is a cyanine dye used in medical diagnostics. |
||
ICG 001 |
||
| BPS Bioscience | 10 mg | EUR 175 |
|
Description: CG001 is a small molecule inhibitor that targets Wnt/β-catenin pathway. It inhibits TCF/β-catenin mediated transcription by competing with β-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM. It can be used to specifically evaluate the role of CBP/beta-catenin association on WNT signaling and cell physiology. |
||
ICG 001 |
||
| BPS Bioscience | 100 mg | EUR 710 |
|
Description: CG001 is a small molecule inhibitor that targets Wnt/β-catenin pathway. It inhibits TCF/β-catenin mediated transcription by competing with β-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM. It can be used to specifically evaluate the role of CBP/beta-catenin association on WNT signaling and cell physiology. |
||
ICG 001 |
||
| BPS Bioscience | 25 mg | EUR 330 |
|
Description: CG001 is a small molecule inhibitor that targets Wnt/β-catenin pathway. It inhibits TCF/β-catenin mediated transcription by competing with β-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM. It can be used to specifically evaluate the role of CBP/beta-catenin association on WNT signaling and cell physiology. |
||
Blood Group A(HE14) Antibody |
|||
| BNCH0235-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE14), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNCAP1089-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Blood Group A(HE10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNCAP1089-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNCB1089-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Blood Group A(HE10), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNCB1089-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE10), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNCH1089-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Blood Group A(HE10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNCH1089-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE14) Antibody |
|||
| BNC700235-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Blood Group A(HE14), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE14) Antibody |
|||
| BNC700235-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE14), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNC701089-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Blood Group A(HE10), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNC701089-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE10), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE14) Antibody |
|||
| BNC800235-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Blood Group A(HE14), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE14) Antibody |
|||
| BNC800235-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE14), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE14) Antibody |
|||
| BNC810235-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Blood Group A(HE14), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE14) Antibody |
|||
| BNC810235-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE14), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNC881089-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Blood Group A(HE10), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Blood Group A(HE10) Antibody |
|||
| BNC881089-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Blood Group A(HE10), CF488A conjugate, Concentration: 0.1mg/mL |
|||
